Search

Your search keyword '"Ribonuclease, Pancreatic chemistry"' showing total 1,459 results

Search Constraints

Start Over You searched for: Descriptor "Ribonuclease, Pancreatic chemistry" Remove constraint Descriptor: "Ribonuclease, Pancreatic chemistry"
1,459 results on '"Ribonuclease, Pancreatic chemistry"'

Search Results

1. Cyanide mediated conformational changes resulted in the displacement of sulfate ion from the active site of bovine pancreatic ribonuclease A.

2. Deciphering the role of neutral diruthenium complexes in protein binding.

3. Solvation free energy in governing equations for DNA hybridization, protein-ligand binding, and protein folding.

4. Assessing Partial Inhibition of Ribonuclease A Activity by Curcumin through Fluorescence Spectroscopy and Theoretical Studies.

5. Responsive Multi-Arm PEG-Modified COF Nanocomposites: Dynamic Photothermal, pH/ROS Dual-Responsive, Targeted Carriers for Rheumatoid Arthritis Treatment.

6. Benchmarking predictive methods for small-angle X-ray scattering from atomic coordinates of proteins using maximum likelihood consensus data.

7. On the Stabilizing Effect of Aspartate and Glutamate and Its Counteraction by Common Denaturants.

8. A highly sensitive nanopore platform for measuring RNase A activity.

9. Dynamics of non-covalent interactions during the P-O bond cleavage reaction by ribonuclease A.

10. Mechanistic studies on substrate inhibition and substrate activation of ribonuclease A: experimental and in silico investigation.

11. Insights into the dynamic interactions of RNase a and osmolytes through computational approaches.

12. Visualizing ribonuclease digestion of RNA-like polymers produced by hot wet-dry cycles.

13. Structural mechanism of angiogenin activation by the ribosome.

14. Long-timescale atomistic simulations uncover loss-of-function mechanisms of uncharacterized Angiogenin mutants associated with ALS.

16. Picoplatin binding to proteins: X-ray structures and mass spectrometry data on the adducts with lysozyme and ribonuclease A.

17. Engineering Human Pancreatic RNase 1 as an Immunotherapeutic Agent for Cancer Therapy Through Computational and Experimental Studies.

18. Sugar osmolyte inhibits and attenuates the fibrillogenesis in RNase A: An in vitro and in silico characterizations.

19. Human RNase 1 can extensively oligomerize through 3D domain swapping thanks to the crucial contribution of its C-terminus.

20. Cross-Linked Crystals of Dirhodium Tetraacetate/RNase A Adduct Can Be Used as Heterogeneous Catalysts.

21. Ribonuclease T2 represents a distinct circularly permutated version of the BECR RNases.

22. The Non-native Disulfide-Bond-Containing Landscape Orthogonal to the Oxidative Protein-Folding Trajectory: A Necessary Evil?

23. Structure of angiogenin dimer bound to double-stranded RNA.

24. Mechanical Stability of Ribonuclease A Heavily Depends on the Redox Environment.

25. Hofmeister Effects of Group II Cations as Seen in the Unfolding of Ribonuclease A.

26. Emerging biological functions of ribonuclease 1 and angiogenin.

27. Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the V IV O-Picolinato Complex with RNase A.

28. Angiogenin and Copper Crossing in Wound Healing.

29. Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands.

30. Shotgun scanning glycomutagenesis: A simple and efficient strategy for constructing and characterizing neoglycoproteins.

31. Dimerization of Human Angiogenin and of Variants Involved in Neurodegenerative Diseases.

32. An Influence of Modification with Phosphoryl Guanidine Combined with a 2'-O-Methyl or 2'-Fluoro Group on the Small-Interfering-RNA Effect.

33. Peptides Derived from Angiogenin Regulate Cellular Copper Uptake.

34. DNAzyme-Catalyzed Cellular Oxidative Stress Amplification for Pro-protein Activation in Living Cells.

35. Optimized protocols for in situ hybridization, immunohistochemistry, and immunofluorescence on skeletal tissue.

36. Development of Nanosilicate-Hydrogel Composites for Sustained Delivery of Charged Biopharmaceutics.

37. Positional preferences in flavonoids for inhibition of ribonuclease A: Where "OH" where?

38. Time-Resolved Acetaldehyde-Based Accessibility Profiling Maps Ligand-Target Interactions.

39. NMR Characterization of Angiogenin Variants and tRNA Ala Products Impacting Aberrant Protein Oligomerization.

40. Biomimetic selenocystine based dynamic combinatorial chemistry for thiol-disulfide exchange.

41. Theoretical Studies on the Effect of Isomerized Aspartic Acid Residues on the Three-Dimensional Structures of Bovine Pancreatic Ribonucleases A.

42. Targeted Delivery of DNA Framework-Encapsulated Native Therapeutic Protein into Cancer Cells.

43. The Enzyme-Free Release of Nucleotides from Phosphoramidates Depends Strongly on the Amino Acid.

44. Construction of polymer monolithic columns in polypropylene ink-pen tubes for separation of proteins by cation-exchange chromatography.

45. Architectural RNA in chromatin organization.

46. Intracellular delivery of therapeutic proteins through N-terminal site-specific modification.

47. Regeneration of Burnt Bridges on a DNA Catenane Walker.

48. Fast construction of polymer monolithic columns inside fluorinated ethylene propylene (FEP) tubes for separation of proteins by reversed-phase liquid chromatography.

49. Enzymatic and Chemical-Based Methods to Inactivate Endogenous Blood Ribonucleases for Nucleic Acid Diagnostics.

50. How good are comparative models in the understanding of protein dynamics?

Catalog

Books, media, physical & digital resources